|Bid||0.0400 x 0|
|Ask||0.0450 x 0|
|Day's Range||0.0400 - 0.0450|
|52 Week Range||0.0250 - 0.3000|
|Beta (5Y Monthly)||1.22|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, BC, Oct. 15, 2020 /CNW/ - Chemistree Technology Inc.
VANCOUVER, BC, Sept. 28, 2020 /CNW/ - Chemistree Technology Inc.
VANCOUVER, BC , July 9, 2020 /CNW/ - Chemistree Technology Inc. (CHM.CN) and (CSE:CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to announce that, further to the news releases dated June 15 th and 18th, 2020, the first tranche of the investment into Immuoflex Therapeutics ("ImmunoFlex") has now closed. The definitive investment agreement includes Chemistree's initial common share purchase of $500,000 , together with Chemistree being granted a gross sales royalty on ImmunoFlex's North American sales. A further $500,000 second tranche common share purchase is conditional on certain performance by ImmunoFlex or at the election of Chemistree.